Cargando…

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

Helicobacter pylori (H. pylori) is a notorious, recalcitrant and silent germ, which can cause a variety of debilitating stomach diseases, including gastric and duodenal ulcers and gastric cancer. This microbe predominantly colonizes the mucosal layer of the human stomach and survives in the inhospit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miri, Amir Hossein, Kamankesh, Mojtaba, Llopis-Lorente, Antoni, Liu, Chenguang, Wacker, Matthias G., Haririan, Ismaeil, Asadzadeh Aghdaei, Hamid, Hamblin, Michael R., Yadegar, Abbas, Rad-Malekshahi, Mazda, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271669/ https://www.ncbi.nlm.nih.gov/pubmed/35833028 http://dx.doi.org/10.3389/fphar.2022.917184

Ejemplares similares

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Sugar Codes Conjugated Alginate: An Innovative Platform to Make a Strategic Breakthrough in Simultaneous Prophylaxis of GERD and Helicobacter pylori Infection
por: Moayedi, Saeed, et al.
Publicado: (2020)

Genetic diversity of Helicobacter pylori type IV secretion system cagI and cagN genes and their association with clinical diseases
por: Azizimoghaddam, Yasaman, et al.
Publicado: (2023)

High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping
por: Farzi, Nastaran, et al.
Publicado: (2019)

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes
por: Alebouyeh, Masoud, et al.
Publicado: (2015)

Nanobiosensor Based on Sugar Code-AuNPs Aggregation: A Key to Opening New Gates in Rapid Diagnosis of Streptococcal Pharyngitis
por: Mohajeri, Sahar, et al.
Publicado: (2022)

Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation
por: Noori, Maryam, et al.
Publicado: (2023)

Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates
por: Alavifard, Helia, et al.
Publicado: (2023)

Additive Manufacturing of an Extended-Release Tablet of Tacrolimus
por: Abdollahi, Azin, et al.
Publicado: (2023)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
por: Rezasoltani, Sama, et al.
Publicado: (2020)

The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
por: Fakharian, Farzaneh, et al.
Publicado: (2022)

The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation
por: Nabavi-Rad, Ali, et al.
Publicado: (2023)

Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
por: Yadegar, Abbas, et al.
Publicado: (2023)

How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19?
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
por: Mohajeri, Sahar, et al.
Publicado: (2022)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen
por: Mohammad Rahimi, Hanieh, et al.
Publicado: (2022)

Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases
por: Yadegar, Abbas, et al.
Publicado: (2019)

Effect of Statins on Helicobacter pylori Eradication Rate: A Systematic Review and Meta-Analysis
por: Rajabnia, Mohsen, et al.
Publicado: (2021)

Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran
por: Azimirad, Masoumeh, et al.
Publicado: (2019)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Design and Fabrication of a High Performance Microfluidic Chip for Blood Plasma Separation: Modelling and Prediction of System Behaviour via CFD Method
por: Amini, Hossein, et al.
Publicado: (2023)

The prevalence of Helicobacter pylori is decreasing in Iranian patients
por: Ashtari, Sara, et al.
Publicado: (2015)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)

Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2022)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Helicobacter pylori CagA induced interleukin-8 secretion in gastric epithelial cells
por: Fazeli, Zeinab, et al.
Publicado: (2016)

Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

The Effects of Helicobacter pylori-Derived Outer Membrane Vesicles on Hepatic Stellate Cell Activation and Liver Fibrosis In Vitro
por: Bolori, Shahin, et al.
Publicado: (2023)

Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review
por: Rezaeimanesh, Nasim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9sobpbhm6ovk6h1okkgv4ncoae